Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues. | Int J Mol Sci | 2021 | 34769066 | PubTator, text mining | PubMed |
| Perirenal Adipose Tissue from Healthy Donor: Characteristics and Promise as Potential Therapeutic Cell Source. | J Clin Med | 2021 | 34768543 | PubTator, text mining | PubMed |
| The marriage of chemokines and galectins as functional heterodimers. | Cell Mol Life Sci | 2021 | 34767039 | PubTator, text mining | PubMed |
| 3-D vascularized breast cancer model to study the role of osteoblast in formation of a pre-metastatic niche. | Sci Rep | 2021 | 34754042 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Aberrant ROS Mediate Cell Cycle and Motility in Colorectal Cancer Cells Through an Oncogenic CXCL14 Signaling Pathway. | Front Pharmacol | 2021 | 34744744 | PubTator, text mining | PubMed |
| Single cell transcriptomics reveals the heterogeneity of the human cornea to identify novel markers of the limbus and stroma. | Sci Rep | 2021 | 34741068 | PubTator, text mining | PubMed |
| The Role of Immune Checkpoint Inhibitors in Leptomeningeal Disease: A Systematic Review. | Anticancer Res | 2021 | 34732403 | PubTator, text mining | PubMed |
| Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions. | J Cancer | 2021 | 34729114 | PubTator, text mining | PubMed |
| Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment. | Cell Cycle | 2021 | 34724861 | PubTator, text mining | PubMed |
| Comprehensive Analysis to Identify the Epithelial-Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma. | Front Surg | 2021 | 34722623 | PubTator, text mining | PubMed |
| Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen. | Oral Oncol | 2021 | 34717154 | PubTator, text mining | PubMed |
| Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer's Disease. | Front Immunol | 2021 | 34712240 | PubTator, text mining | PubMed |
| p21 produces a bioactive secretome that places stressed cells under immunosurveillance. | Science | 2021 | 34709885 | PubTator, text mining | PubMed |
| Irisin Stimulates the Release of CXCL1 From Differentiating Human Subcutaneous and Deep-Neck Derived Adipocytes via Upregulation of NFκB Pathway. | Front Cell Dev Biol | 2021 | 34708041 | PubTator, text mining | PubMed |
| MiR-3188 regulates the proliferation and apoptosis of hepatocellular carcinoma cells by targeting CXCL14. | Biomark Med | 2021 | 34704819 | PubTator, text mining | PubMed |
| The roles of Y-box-binding protein (YB)-1 and C-X-C motif chemokine ligand 14 (CXCL14) in the progression of prostate cancer via extracellular-signal-regulated kinase (ERK) signaling. | Bioengineered | 2021 | 34696665 | PubTator, text mining | PubMed |
| Melanocytes in black-boned chicken have immune contribution under infectious bursal disease virus infection. | Poult Sci | 2021 | 34695633 | PubTator, text mining | PubMed |
| Prognostic Significance of Dysregulated Epigenomic and Chromatin Modifiers in Cervical Cancer. | Cells | 2021 | 34685645 | PubTator, text mining | PubMed |
| Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction. | Cells | 2021 | 34685518 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=51